{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:58:44Z","timestamp":1763535524249,"version":"3.41.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ancard.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T12:44:47Z","timestamp":1525869887000},"page":"208-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Severe renal failure and thrombotic microangiopathy induced by malignant hypertension successfully treated with spironolactone"],"prefix":"10.1016","volume":"67","author":[{"given":"H.M.","family":"Villafuerte Ledesma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Pe\u00f1a Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"I\u00f1igo Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Martin Azara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E","family":"Ruiz Lalglesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tom\u00e1s LaTorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00ednez Burillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vernet Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"\u00c1lvarez Lipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ancard.2018.04.009_bib0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2017.05.017","article-title":"Thrombotic microangiopathy: a multidisciplinary team approach","volume":"70","author":"Gordon","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"10.1016\/j.ancard.2018.04.009_bib0110","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2169\/internalmedicine.55.6332","article-title":"Malignant hypertension with thrombotic microangiopathy","volume":"55","author":"Mitaka","year":"2016","journal-title":"Intern Med"},{"issue":"7","key":"10.1016\/j.ancard.2018.04.009_bib0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2018.04.009_bib0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.12659\/AJCR.892787","article-title":"Malignant hypertension and thrombotic thrombocytopenic purpura: false friends","volume":"16","author":"Abdalla","year":"2015","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.ancard.2018.04.009_bib0125","first-page":"2017","article-title":"Malignant hypertension as a rare cause of thrombotic microangiopathy","author":"Thind","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ancard.2018.04.009_bib0130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.20452\/pamw.3275","article-title":"Malignant hypertension: new aspects of an old clinical entity","volume":"126","author":"Januszewicz","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.ancard.2018.04.009_bib0135","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","article-title":"Longterm renal survival in malignant hypertension","volume":"25","author":"Gonz\u00e1lez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ancard.2018.04.009_bib0140","series-title":"Wintrobe's clinical hematology","first-page":"1305","article-title":"Red cell fragmentation syndromes","author":"Foerster","year":"1999"},{"key":"10.1016\/j.ancard.2018.04.009_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/10641963.2010.503303","article-title":"Clinical features of malignant hypertension with thrombotic microangiopathy","volume":"33","author":"Akimoto","year":"2011","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ancard.2018.04.009_bib0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","article-title":"Microangiopathic hemolysis and renal failure in malignant hypertension","volume":"45","author":"Van den Born","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ancard.2018.04.009_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ancard.2018.04.009_bib0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocy \u2013 topenic purpura-hemolytic uremic syndrome","volume":"96","author":"George","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ancard.2018.04.009_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2040620715571076","article-title":"Differentiating malignant hypertension induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura","volume":"6","author":"Khanal","year":"2015","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.009_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2018.04.009_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2015.09.790","article-title":"Network meta-analysis of various treatment strategies in resistant hypertension","volume":"18","author":"Makai","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.ancard.2018.04.009_bib0180","first-page":"7270","article-title":"Clinical efficacy of spironolactone for resistant hypertension: a meta-analysis from randomized controlled clinical trials","volume":"8","author":"Guo","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.ancard.2018.04.009_bib0185","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ajh\/hpv031","article-title":"The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies","volume":"28","author":"Dahal","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ancard.2018.04.009_bib0190","first-page":"290","article-title":"Medical and interventional therapies for patients with resistant hypertension, a network meta-analysis","volume":"9","author":"D\u2019Ascenzo","year":"2013","journal-title":"Euro Intervention"},{"issue":"4","key":"10.1016\/j.ancard.2018.04.009_bib0195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2016.04.011","article-title":"The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis","volume":"68","author":"Quach","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ancard.2018.04.009_bib0200","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities","volume":"91","author":"Timmermans SAMEG","year":"2017","journal-title":"Kidney Int"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818300532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818300532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:38:32Z","timestamp":1751629112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392818300532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0003392818300532"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2018.04.009","relation":{},"ISSN":["0003-3928"],"issn-type":[{"type":"print","value":"0003-3928"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe renal failure and thrombotic microangiopathy induced by malignant hypertension successfully treated with spironolactone","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}